Lung Disease News and Research

RSS

People exposed to North Dakota road materials face increase risk of developing mesothelioma

New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated with asbestos exposure, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.

10 Dec 2010

Expansion of newborn screening throws some families on a journey of great uncertainty

Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.

7 Dec 2010

Music benefits patients on mechanical ventilation

The benefits of listening to music for patients on mechanical ventilation was revealed in a systematic review by a team of Cochrane researchers led by Drexel University College of Nursing and Health Professions associate professor Dr. Joke Bradt. The review found that listening to music may relax patients and potentially result in fewer complications.

4 Dec 2010

CAIRE enters definitive agreement to acquire SeQual

Chart Industries, Inc. announced that its wholly-owned subsidiary, CAIRE Inc., which operates under its BioMedical segment, has entered into a definitive agreement to acquire SeQual Technologies Inc. for approximately $40 million, plus the possibility of up to $20 million of additional future payments contingent on SeQual's financial performance over a two-year period post-closing.

From CAIRE Inc 2 Dec 2010

NHS to develop new treatment options for patients with lung disease

Scientists and clinicians in Nottingham are to work more closely with industry to develop new ways of diagnosing and treating lung disease.

2 Dec 2010

'Telehealth' devices allow patients to track illnesses from home

Thousands of seriously ill patients are relying on computerized health trackers to help keep them safe at home.

23 Nov 2010

Nanotrope assay receives U.S. patent for diagnosing influenza and viral infections

Nanotrope, Inc. announced today that it has been issued United States patent #7,829,272 covering its ground-breaking diagnostic test for influenza and other viral infections.

17 Nov 2010

New investigational drug is well tolerated in children with nmCF

PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine.

15 Nov 2010

Lung cancer in smokers versus non-smokers shows different genetic mutations

A group of scientists at B.C. Cancer Agency have found that lung cancers in smokers have different genetic mutations and look different than lung cancer in non-smokers. According to senior scientist at the BC Cancer Agency Research Centre Wan Lam, this finding is significant because it means that from now on, research, treatments and diagnostics should be tailored to the distinct genetic variations in the different lung cancers instead of expecting that a one-size fits all approach will work. He said, “At the current time, treatment does not distinguish between these different types. The subtypes are all grouped together. But with this work, we are beginning to tease out the subtypes.” The study was presented Tuesday at a conference in Philadelphia of the American Association of Cancer Research.

10 Nov 2010

NHLBI launches new campaign to highlight common COPD symptoms

The number of Americans who report being aware of chronic obstructive pulmonary disease, or COPD, increased by 4 percentage points between 2008 and 2010, but many people at risk are still unaware of the disease, according to mailed survey results released today by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

10 Nov 2010

Screening heavy smokers for lung cancer reduces chance of death, federal study finds

The Boston Globe: "Screening heavy smokers with sophisticated medical scanners modestly reduced their chance of dying from lung cancer, according to a federal study released yesterday that provides the first convincing evidence that testing could reduce the toll from the leading cause of cancer deaths. The preliminary findings from the National Cancer Institute were based on a gold-standard study that randomly assigned 53,000 current or former smokers without symptoms to be screened with a CT scanner or standard chest X-ray.

8 Nov 2010

New iPSC cell lines could help in treating patients with lung diseases

A team of researchers from Boston University's Center for Regenerative Medicine and the Pulmonary Center have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases.

29 Oct 2010

Non communicable diseases will cost India USD237 billion during 2006-15

Health experts participating at a roundtable organised by India Health Progress(IHP) on economic and social impact of non-communicable diseases in India are of the opinion that a concerted effort is required to address the growing burden.

25 Oct 2010

Experts identify efficient way to increase minority access to colorectal cancer screening

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.

25 Oct 2010

72% of patients misdiagnosed with pneumonia upon readmission : Study

Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

25 Oct 2010

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

Inspire Pharmaceuticals, Inc. announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the 24th Annual North American Cystic Fibrosis Conference (NACFC) October 21-23, 2010 in Baltimore, Maryland.

22 Oct 2010

Protein IL-37 could help treat inflammatory diseases in adults and children

A husband and wife research team from Melbourne, Australia, have identified a protein that may be a key therapy for many inflammatory diseases, including those affecting premature babies.

21 Oct 2010

Cipla launches generic Pirfenidone for IPF

Cipla, among the world's leading generic pharmaceutical companies, has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. A chronic progressive form of lung disease, IPF has average survival rates as low as 3-5 years which is less than many cancers. Till now there is no approved treatment for IPF.

20 Oct 2010

Study reinforces need for physicians to screen obstructive sleep apnea prior to surgery

As Americans get heavier and heavier, the incidence of obstructive sleep apnea increases, and results from two clinical studies presented at ANESTHESIOLOGY 2010 reinforce the need for physicians to screen for the disorder prior to surgery in order to appropriately manage the patient in the operating room.

18 Oct 2010

Discovery Labs to present lucinactant Phase 2a clinical study results at NACFC Conference

Discovery Laboratories, Inc. today announces that the Phase 2a clinical study of aerosolized KL4 surfactant (lucinactant) in patients with cystic fibrosis (CF) has completed and the results from the study will be presented at the upcoming North American Cystic Fibrosis Conference (NACFC; October 21-23, 2010).

15 Oct 2010

Lung Disease News and Research

People exposed to North Dakota road materials face increase risk of developing mesothelioma

Expansion of newborn screening throws some families on a journey of great uncertainty

Music benefits patients on mechanical ventilation

CAIRE enters definitive agreement to acquire SeQual

NHS to develop new treatment options for patients with lung disease

'Telehealth' devices allow patients to track illnesses from home

Nanotrope assay receives U.S. patent for diagnosing influenza and viral infections

New investigational drug is well tolerated in children with nmCF

Lung cancer in smokers versus non-smokers shows different genetic mutations

NHLBI launches new campaign to highlight common COPD symptoms

Screening heavy smokers for lung cancer reduces chance of death, federal study finds

New iPSC cell lines could help in treating patients with lung diseases

Non communicable diseases will cost India USD237 billion during 2006-15

Experts identify efficient way to increase minority access to colorectal cancer screening

72% of patients misdiagnosed with pneumonia upon readmission : Study

Inspire presents data on denufosol therapy for cystic fibrosis at NACFC conference

Protein IL-37 could help treat inflammatory diseases in adults and children

Cipla launches generic Pirfenidone for IPF

Study reinforces need for physicians to screen obstructive sleep apnea prior to surgery

Discovery Labs to present lucinactant Phase 2a clinical study results at NACFC Conference

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News